Stock listing
Pexa Ab Class B
Selected listing: FA0 · FWB · EUR · DE
Pexa Ab Class B (Frankfurt:FA0), Health Technology. Latest release May 22, 2026: PEXA.B: Q1 2026 saw strong sales growth, improved results, and key research…
- Ticker
- Frankfurt:FA0
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- Frankfurt
- Currency
- EUR
About Pexa Ab Class B
The company is focused on its operations within the market, providing insights into its business activities and performance. Investors can find relevant information about Pexa Ab Class B on its public company page.
Latest news from Pexa Ab Class B
PEXA.B: Q1 2026 saw strong sales growth, improved results, and key research orders, but more funding is needed
May 22, 2026
PEXA.B: Strategic refocus on lung cancer diagnostics, narrowed losses, and improved cash position
February 19, 2026
PEXA.B: Q3 revenue up 41%, rights issue secures 9.9 MSEK for diagnostic expansion
November 7, 2025
PEXA.B: Revenue up, losses narrowed, and a guaranteed rights issue launched to fund clinical expansion
August 29, 2025
PEXA.B: No Q1 revenue as PEXA pivots to clinical focus; funding needed amid strong tech validation
May 9, 2025